latest news releases from the newsroom
A Woman's Startling Story -- A Remarkable Memoir Reveals An Incredible Secret
LISBON, Conn., Aug. 1, 2008 (PRIME NEWSWIRE) -- Is the history that you know really a true story? Maybe there is a secret aspect to the journey of mankind -- and womankind -- that has been kept hidden, except for the initiated? In I Am Why They Killed Diana: The Secret of the Red String, know the life of someone whose family possesses a secret passed on through the centuries.
Roma Financial Corporation
Roma Financial Corporation Announces Second Quarter 2008 Earnings
ROBBINSVILLE, N.J., Aug. 1, 2008 (PRIME NEWSWIRE) -- Roma Financial Corporation (Nasdaq:ROMA) (the "Company"), the holding company of Roma Bank, announced today its results of operation for the three and six months ended June 30, 2008. The Company's consolidated net income for the three and six months ended June 30, 2008 was $1.2 million and $2.4 million, respectively. Earnings per share were $.04 and $.08 for the three and six months ended June 30, 2008, respectively, compared to $.08 and $.12 for the same periods in the prior year.
Results With Epratuzumab in Children With Acute Lymphoblastic Leukemia Published in Journal of Clinical Oncology
MORRIS PLAINS, N.J., Aug. 1, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced today that epratuzumab in combination with chemotherapy produced promising results in children with relapsed acute lymphoblastic leukemia (ALL), including 9 patients achieving a complete response. Results from this study were published in the August 1, 2008 issue of the Journal of Clinical Oncology, entitled "Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study," by E.A. Raetz, M.S. Cairo, M.J. Borowitz, S.M. Blaney, M.D. Krailo, T.A. Leil, J.M. Reid, D.M. Goldenberg, W.A. Wegener, W.L. Carroll and P.C. Adamson.
Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation Announces Intent to File Form 10
KENNEWICK, Wash., Aug. 1, 2008 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pink Sheets: ADMD) (http:www.isotopeworld.com) announced that it is preparing to file a registration statement on Form 10 with the Securities and Exchange Commission ("SEC"). Advanced Medical recently completed an audit of its financial statements and has engaged Sichenzia Ross Friedman Ference ("SRFF") to prepare its Form 10. After the Form 10 is filed and becomes effective, AMIC will become a public reporting company and will be required to file annual, quarterly and current reports as well as other information with the SEC.